These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2567391)

  • 1. Alpha-interferon treatment of patient with hyper IgE syndrome.
    Souillet G; Rousset F; de Vries JE
    Lancet; 1989 Jun; 1(8651):1384. PubMed ID: 2567391
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma exchange in a patient with hyper-IgE syndrome.
    Ishikawa I; Fukuda Y; Kitada H; Yuri T; Shinoda A; Hayakawa Y; Sawano K; Usui T
    Ann Allergy; 1982 Nov; 49(5):295-7. PubMed ID: 7149343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyper-IgE syndrome].
    Gahr M; Allgeier B; Speer CP
    Monatsschr Kinderheilkd; 1987 Jun; 135(6):329-35. PubMed ID: 3614229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyper-IgE syndrome treated with interferon alpha 2 beta. Report of a case].
    Segura Mendez NH; del Rivero Hernández L; Mejía Ortega J; Ubaldo Ortiz Vázquez J; Varela Delgado AL; Espínola Reyna G; Rico G
    Rev Alerg Mex; 2000; 47(6):186-9. PubMed ID: 11558395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hyper-IgE-syndrome (Buckley- or Job-syndrome)].
    Belohradsky BH; Däumling S; Kiess W; Griscelli C
    Ergeb Inn Med Kinderheilkd; 1987; 55():1-39. PubMed ID: 3545808
    [No Abstract]   [Full Text] [Related]  

  • 6. The hyper IgE syndrome: clinical and therapeutic aspects.
    Businco L; Galli E; Rossi P
    Allergol Immunopathol (Madr); 1979; 7(6):445-50. PubMed ID: 539529
    [No Abstract]   [Full Text] [Related]  

  • 7. Remission of hyper-IgE syndrome treated with plasmapheresis and cytotoxic immunosuppression.
    Dau PC
    J Clin Apher; 1988; 4(1):8-12. PubMed ID: 3391990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome.
    Del Prete G; Tiri A; Maggi E; De Carli M; Macchia D; Parronchi P; Rossi ME; Pietrogrande MC; Ricci M; Romagnani S
    J Clin Invest; 1989 Dec; 84(6):1830-5. PubMed ID: 2531758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hyper IgE syndrome (Buckley syndrome)].
    Laurent J; Rostoker G; Lagrue G
    Allerg Immunol (Paris); 1989 Sep; 21(7):268-9, 272. PubMed ID: 2789672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyper IgE syndrome: four case report.
    Pigatto PD; Polenghi MM; Altomare GF; Brugo AM; Tadini GL; Morelli M
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):378-82. PubMed ID: 6549138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual case of hyper-production of IgE, treated by plasmapheresis.
    Di Prisco-Fuenmayor MC; Lynch NR; López RI; Rondón AJ; Reyes O; Ulrich M; Castés M; Goihman-Yahr M; Bosch N; García M
    Allergol Immunopathol (Madr); 1986; 14(1):65-70. PubMed ID: 3515885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis.
    Paganelli R; Scala E; Capobianchi MR; Fanales-Belasio E; D'Offizi G; Fiorilli M; Aiuti F
    Clin Exp Immunol; 1991 Apr; 84(1):28-33. PubMed ID: 1901779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkitts lymphoma developing in a child with hyper immunoglobulin E syndrome.
    Pherwani AV; Chandiwal MM; Bavdekar MA; Dasgupta A
    Indian Pediatr; 2001 Mar; 38(3):284-7. PubMed ID: 11255308
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome.
    Ishizaka A; Joh K; Shibata R; Wagatsuma Y; Nakanishi M; Tomizawa K; Kojima K; Kandil E; Sakiyama Y; Matsumoto S
    Immunology; 1990 Jul; 70(3):414-6. PubMed ID: 2116376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A remarkable effect of alpha-interferon in a case of angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) refractory to steroids and combination chemotherapies].
    Imoto S; Ito M; Nakagawa T
    Rinsho Ketsueki; 1991 Jun; 32(6):681-5. PubMed ID: 1890746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper immunoglobulin E syndrome.
    Geha RS; Leung DY
    Immunodefic Rev; 1989; 1(2):155-72. PubMed ID: 2698640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.
    Kesarwala HH; Prasad RV; Szep R; Oldman E; Lane S; Papageorgiou PS
    Clin Exp Immunol; 1979 Jun; 36(3):465-72. PubMed ID: 487648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyper-IgE syndrome].
    Kaajan JP; van der Meer JW; van den Broek PJ; Dooren LJ; de Graaff CS; van Furth R
    Ned Tijdschr Geneeskd; 1985 Mar; 129(12):540-6. PubMed ID: 3990840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Highly malignant non-Hodgkin's lymphoma in hyper-IgE syndrome].
    Einsele H; Saal JG; Dopfer R; Niethammer D; Waller HD; Müller CA
    Dtsch Med Wochenschr; 1990 Jul; 115(30):1141-4. PubMed ID: 2379459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome.
    Leung DY; Key L; Steinberg JJ; Young MC; Von Deck M; Wilkinson R; Geha RS
    J Immunol; 1988 Jan; 140(1):84-8. PubMed ID: 3422080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.